Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1Gastrointestinal 1

Conditions

Papillomavirus Infections 1Anus Neoplasms 1

Interventions

Oxaliplatin 197Bevacizumab 161Fluorouracil 154Capecitabine 137Gemcitabine 134Leucovorin 111pembrolizumab 99Cisplatin 94Drug Therapy 89Irinotecan 80Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 66durvalumab 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 47Biopsy 46Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cytological Techniques × Gastrointestinal × Clear all
NCT06574087 2025-07-23

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

PCK Marine Hospital in Gdynia

Phase NA Recruiting
248 enrolled
Gastrointestinal

Anus Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡